Navaneethan Palanisamy

Mr Navaneethan Palanisamy

B.Tech., M.MedSc., M.Sc.

University of Heidelberg

Heidelberg, Baden Würtumberg | Germany

Navaneethan Palanisamy

Mr Navaneethan Palanisamy

B.Tech., M.MedSc., M.Sc.
Introduction

Primary Affiliation: University of Heidelberg - Heidelberg, Baden Würtumberg , Germany

Metrics

10

Publications

1169

Profile Views

77

Reads

40

PubMed Central Citations

Top co-authors
Johan Lennerstrand
Johan Lennerstrand

Uppsala University

5
Chakradhar Kokkula
Chakradhar Kokkula

Uppsala University

2
Hong Yin
Hong Yin

Lanzhou Veterinary Research Institute

2
Axel Danielsson
Axel Danielsson

Uppsala University

2
Ulrike Goedecke
Ulrike Goedecke

German Primate Center

1
Stefan Pohlmann
Stefan Pohlmann

German Primate Center

1
Michael Winkler
Michael Winkler

Hannover Medical School

1

Publications

10Publications

77Reads

40PubMed Central Citations

Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach.

Interdiscip Sci 2018 Mar 16;10(1):143-156. Epub 2016 Jun 16.

Section of Clinical Virology, Department of Medical Sciences, Uppsala University, 751 85, Uppsala, Sweden.

View Article
March 2018
11 Reads

Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study.

AIDS Res Ther 2017 Jan 7;14(1). Epub 2017 Jan 7.

McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755, Ch. Cote-Ste-Catherine, Montréal, QC, Canada.

View Article
January 2017
11 Reads
1 PubMed Central Citation(source)
1.84 Impact Factor

SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase.

Mol Biotechnol 2016 Oct;58(10):619-625

Section of Virology, Department of Medical Sciences, Uppsala University, Dag Hammarskjölds väg 17, 75185, Uppsala, Sweden.

View Article
October 2016
11 Reads
1.88 Impact Factor

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden.

Infect Dis (Lond) 2015 Aug 8;47(8):555-62. Epub 2015 Apr 8.

From the 1 Clinical Virology, Department of Medical Sciences, Uppsala University , Uppsala.

View Article
August 2015
13 Reads
7 PubMed Central Citations(source)

Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins.

PLoS One 2014 19;9(5):e97695. Epub 2014 May 19.

Infection Biology Unit, German Primate Center, Göttingen, Germany.

View Article
January 2015
11 Reads
14 PubMed Central Citations(source)
3.23 Impact Factor

Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden.

Infect Ecol Epidemiol 2014 Jan 15;4. Epub 2014 Jan 15.

Section of Clinical Virology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

View Article
January 2014
9 Reads
2 PubMed Central Citations(source)

Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a.

Antiviral Res 2013 Jul 3;99(1):12-7. Epub 2013 May 3.

Clinical Virology, Department of Medical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden.

View Article
July 2013
11 Reads
16 PubMed Central Citations(source)
3.94 Impact Factor
Top co-authors
Johan Lennerstrand
Johan Lennerstrand

Uppsala University

5
Chakradhar Kokkula
Chakradhar Kokkula

Uppsala University

2
Hong Yin
Hong Yin

Lanzhou Veterinary Research Institute

2
Axel Danielsson
Axel Danielsson

Uppsala University

2
Ulrike Goedecke
Ulrike Goedecke

German Primate Center

1
Stefan Pohlmann
Stefan Pohlmann

German Primate Center

1
Michael Winkler
Michael Winkler

Hannover Medical School

1
Followers